Betamethasone
Indications
Registered South African indications:
- Inflammatory conditions of the eye
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Infections of the eye
- Glaucoma
- Herpetic keratitis
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Undiagnosed red eye
- Prolonged use
- Concomitant use of soft contact lenses
- Infants
Adult dosage
Forms avail. in SA and covered in this monograph: opd
Non-infective inflammatory conditions of the eye
- Ophthalmic (opd): Initial: 1-2 drops into affected eye(s), 2hrly; Reduce frequency once symptoms improve
Paediatric dosage
See adult dosage
Special populations
Pregnancy
- Caution
- Safety for use in pregnancy has not been established. There is inadequate evidence of safety in human pregnancy. Topical administration of corticosteroids to pregnant animals can cause abnormal foetal development including cleft palate and intrauterine growth retardation. There may, therefore, be a very small risk of such defects in the human foetus
Breastfeeding
- Caution
- Safety for use in breastfeeding has not been established. There is inadequate evidence of safety in humans
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity disorders
Sensory Disorders
- Increased intraocular pressure
- Optic nerve damage
- Reduced visual acuity
- Visual field defect
- Posterior subcapsular cataracts
- Globe perforation
Interactions
No known significant interactions
Monitoring
None routine. Specific cases may require
- Ophthalmic examination
Mechanism of action
Betamethasone sodium phosphate is a corticosteroid used topically in the treatment of inflammatory conditions. The anti-inflammatory action of this drug is thought to involve lipocortins, which are phospholipase A2 inhibitory proteins that control the biosynthesis of prostaglandins and leukotrienes.
Dosage forms
- Eye drops
- Ear/eye/nose drops
Formulation
Eye drops (per 100ml) 0.1g
- Betnesol (Aspen)
Also available in the following forms: Nose drop, cream, ointment, lotion, tablet, syrup and injection.
COMBINATION PREPARATIONS
Betamethasone/ Neomycin
Ear/Nose drops (per 100ml) 0.1g/0.35g
- Betnesol-N (Pharmacare) originator
References
1. SAMF_11th Edition_Page 576+592 2. SmPC: Betamethasone 0.1% w/v Drops, Martindale Pharma:Last updated on eMC: 24 Aug 2018; Downloaded online 19 Nov 2018 [https://drive.google.com/drive/u/0/folders/1gpM5NS-btTbkuQo2EQ6lEsUi9f3S1V8z] 3. PI: Betnesol eye, ear and nose drops; Intekom; Downloaded online 19 Nov 2018 [https://drive.google.com/drive/u/0/folders/1gpM5NS-btTbkuQo2EQ6lEsUi9f3S1V8z] 4. Drugs.com: Betamethasone; Downloaded online 19 Nov 2018 [https://drive.google.com/drive/u/0/folders/1gpM5NS-btTbkuQo2EQ6lEsUi9f3S1V8z] 5. NAPOS The Drug Database for Acute Porphyria: S01BA06 Betamethasone; Accessed online 10 Sep 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=S01BA06&l=gbr] 6. South African Institute for Drug-Free Sport: Betnesol Drops, Ointment; Accessed online 10 Sep 2018 [http://www.drugfreesport.org.za/online-medication-check/] 7. AfriTox: Betamethasone; Downloaded online 23 July 2020; Last accessed online 23 July 2020 [https://www.afritox.co.za/hp/SingleToxin/SingleToxin.aspx?SingleToxinID=2572]
Brands & products
1 product · cached snapshot- Betnesol
EENEar/eye/nose drops· 1 product
from R245.64| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Betnesol | 0.1 g/100ml | 5 | Adcock Ingram Limited | R245.64 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
Interacts with 12 known drugs
Check against other drugs →Cited in 41 documents
- GuidelinesNonopioid Analgesics and Co-Analgesics4×
- GuidelinesReferences4×
- GuidelinesReferences - Obstetrics and Gynaecology4×
- GuidelinesCircular 3 April 2025: Interruption in the Supply of Betamethasone Disodium Phosphate 4mg/ml Injection3×
- ArticlesInterruption in the Supply of Betamethasone Disodium Phosphate 4mg/ml Injection3×
- GuidelinesPreterm Labour (PTL) and Preterm Prelabour Rupture of Membranes (PPROM)3×
- GuidelinesHIV Papular Pruritic Eruption2×
- GuidelinesIntrauterine Growth Restriction2×
- GuidelinesManagement of Hypertensive Disorders of Pregnancy2×
- GuidelinesMultiple Pregnancy2×
- GuidelinesNausea And Vomiting - Paediatric Palliative Care2×
- GuidelinesOedema, Cerebral2×
- GuidelinesPrelabour Rupture of the Membranes2×
- GuidelinesPreterm Labour2×
- GuidelinesPreterm Labour (PTL) and Preterm Prelabour Rupture of Membranes (PPROM)2×
- GuidelinesProtocol for the Acute Management of Spontaneous Preterm Labour at Tygerberg Hospital2×
- GuidelinesPsoriasis2×
- GuidelinesPsoriasis2×
- GuidelinesReferences - Medicines used in Palliative Care2×
- GuidelinesReferences - Obstetrics2×
- GuidelinesAcute Management of Abdominal Trauma in Pregnancy
- GuidelinesAntepartum Haemorrhage
- GuidelinesAtopic Eczema/Dermatitis
- GuidelinesCIRCULAR H 111 of 2020 - The RECOVERY Study: Interim Guidance on the Use of Steroids in COVID-19 patients
- GuidelinesChorioamnionitis
- GuidelinesClinical Management of Suspected or Confirmed COVID-19 Disease, Version 5
- GuidelinesCushing Syndrome
- GuidelinesDermatitis, Seborrhoeic
- GuidelinesDiabetes Mellitus
- GuidelinesEczema
- GuidelinesEczema, Atopic
- GuidelinesGeneral - Pain Assessment and Management
- GuidelinesNeurocysticercosis
- GuidelinesNeuropathic Pain
- GuidelinesPapular Urticaria
- GuidelinesParonychia, Chronic
- GuidelinesPoor Obstetric History
- GuidelinesProtocol for the Acute Management of Spontaneous Preterm Prelabour Rupture for Membranes
- GuidelinesPsoriasis
- GuidelinesUrticaria
- GuidelinesVulval Skin Problems, Dysplasias & Vulvodynia